nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—NISCH—adrenal cortex—asthma	0.00407	0.105	CbGeAlD
Naphazoline—NISCH—bronchus—asthma	0.00399	0.103	CbGeAlD
Naphazoline—NISCH—smooth muscle tissue—asthma	0.00391	0.101	CbGeAlD
Naphazoline—NISCH—trachea—asthma	0.00359	0.0924	CbGeAlD
Naphazoline—NISCH—adrenal gland—asthma	0.00294	0.0757	CbGeAlD
Naphazoline—NISCH—lung—asthma	0.00258	0.0664	CbGeAlD
Naphazoline—Sweating—Ipratropium bromide—asthma	0.00251	0.00391	CcSEcCtD
Naphazoline—Nervousness—Theophylline—asthma	0.00251	0.0039	CcSEcCtD
Naphazoline—Hyperhidrosis—Orciprenaline—asthma	0.00243	0.00378	CcSEcCtD
Naphazoline—Hyperglycaemia—Aminophylline—asthma	0.00243	0.00378	CcSEcCtD
Naphazoline—Somnolence—Ketotifen—asthma	0.00236	0.00367	CcSEcCtD
Naphazoline—Asthenia—Isoprenaline—asthma	0.00233	0.00363	CcSEcCtD
Naphazoline—Hyperglycaemia—Tiotropium—asthma	0.00229	0.00357	CcSEcCtD
Naphazoline—Somnolence—Zileuton—asthma	0.00229	0.00356	CcSEcCtD
Naphazoline—Discomfort—Zafirlukast—asthma	0.00228	0.00354	CcSEcCtD
Naphazoline—Keratitis—Betamethasone—asthma	0.00228	0.00354	CcSEcCtD
Naphazoline—Keratitis—Dexamethasone—asthma	0.00228	0.00354	CcSEcCtD
Naphazoline—Drowsiness—Loratadine—asthma	0.00227	0.00353	CcSEcCtD
Naphazoline—Asthenia—Terbutaline—asthma	0.00224	0.00349	CcSEcCtD
Naphazoline—Erythema—Cromoglicic acid—asthma	0.00224	0.00349	CcSEcCtD
Naphazoline—Somnolence—Orciprenaline—asthma	0.00224	0.00348	CcSEcCtD
Naphazoline—Mydriasis—Prednisolone—asthma	0.00222	0.00345	CcSEcCtD
Naphazoline—Tension—Cromoglicic acid—asthma	0.0022	0.00342	CcSEcCtD
Naphazoline—Eye disorder—Ipratropium bromide—asthma	0.0022	0.00342	CcSEcCtD
Naphazoline—Nervousness—Cromoglicic acid—asthma	0.00218	0.00339	CcSEcCtD
Naphazoline—Somnolence—Pirbuterol—asthma	0.00218	0.00338	CcSEcCtD
Naphazoline—Dizziness—Isoprenaline—asthma	0.00215	0.00334	CcSEcCtD
Naphazoline—Hypertension—Ciclesonide—asthma	0.00213	0.00331	CcSEcCtD
Naphazoline—Eye disorder—Fluticasone Propionate—asthma	0.00213	0.00331	CcSEcCtD
Naphazoline—Headache—Dyphylline—asthma	0.0021	0.00326	CcSEcCtD
Naphazoline—Dizziness—Terbutaline—asthma	0.00207	0.00321	CcSEcCtD
Naphazoline—Headache—Isoprenaline—asthma	0.00204	0.00317	CcSEcCtD
Naphazoline—Sweating—Flunisolide—asthma	0.00201	0.00313	CcSEcCtD
Naphazoline—Tension—Ipratropium bromide—asthma	0.00201	0.00313	CcSEcCtD
Naphazoline—Nervousness—Ipratropium bromide—asthma	0.00199	0.00309	CcSEcCtD
Naphazoline—Nausea—Dyphylline—asthma	0.00199	0.00309	CcSEcCtD
Naphazoline—Erythema—Fluticasone Propionate—asthma	0.00198	0.00308	CcSEcCtD
Naphazoline—Headache—Terbutaline—asthma	0.00196	0.00305	CcSEcCtD
Naphazoline—ADRA1A—epithelium—asthma	0.00194	0.0501	CbGeAlD
Naphazoline—Tension—Salmeterol—asthma	0.00194	0.00302	CcSEcCtD
Naphazoline—Nausea—Isoprenaline—asthma	0.00193	0.003	CcSEcCtD
Naphazoline—Vision blurred—Ipratropium bromide—asthma	0.00193	0.003	CcSEcCtD
Naphazoline—Nervousness—Salmeterol—asthma	0.00192	0.00299	CcSEcCtD
Naphazoline—Eye disorder—Tiotropium—asthma	0.0019	0.00296	CcSEcCtD
Naphazoline—Discomfort—Cromoglicic acid—asthma	0.00189	0.00293	CcSEcCtD
Naphazoline—Vision blurred—Fluticasone Propionate—asthma	0.00187	0.00291	CcSEcCtD
Naphazoline—ADRA2C—adrenal cortex—asthma	0.00186	0.0479	CbGeAlD
Naphazoline—Nausea—Terbutaline—asthma	0.00186	0.00289	CcSEcCtD
Naphazoline—Hyperglycaemia—Formoterol—asthma	0.00185	0.00288	CcSEcCtD
Naphazoline—Hyperglycaemia—Arformoterol—asthma	0.00185	0.00288	CcSEcCtD
Naphazoline—Tension—Aminophylline—asthma	0.00184	0.00287	CcSEcCtD
Naphazoline—Nervousness—Aminophylline—asthma	0.00183	0.00284	CcSEcCtD
Naphazoline—ADRA2C—bronchus—asthma	0.00182	0.047	CbGeAlD
Naphazoline—Asthenia—Orciprenaline—asthma	0.00181	0.00281	CcSEcCtD
Naphazoline—Drowsiness—Montelukast—asthma	0.00179	0.00279	CcSEcCtD
Naphazoline—ADRA1A—cardiovascular system—asthma	0.00178	0.0459	CbGeAlD
Naphazoline—Hypertension—Ipratropium bromide—asthma	0.00177	0.00275	CcSEcCtD
Naphazoline—Asthenia—Nedocromil—asthma	0.00177	0.00275	CcSEcCtD
Naphazoline—Dizziness—Ketotifen—asthma	0.00176	0.00273	CcSEcCtD
Naphazoline—Asthenia—Pirbuterol—asthma	0.00176	0.00273	CcSEcCtD
Naphazoline—Hyperglycaemia—Salbutamol—asthma	0.00175	0.00272	CcSEcCtD
Naphazoline—Tension—Loratadine—asthma	0.00174	0.00271	CcSEcCtD
Naphazoline—Drowsiness—Salbutamol—asthma	0.00173	0.00269	CcSEcCtD
Naphazoline—Nervousness—Loratadine—asthma	0.00172	0.00268	CcSEcCtD
Naphazoline—Hypertension—Fluticasone Propionate—asthma	0.00171	0.00266	CcSEcCtD
Naphazoline—Hypertension—Salmeterol—asthma	0.00171	0.00266	CcSEcCtD
Naphazoline—Dizziness—Zileuton—asthma	0.0017	0.00265	CcSEcCtD
Naphazoline—Dizziness—Indacaterol—asthma	0.00168	0.00261	CcSEcCtD
Naphazoline—Vision blurred—Tiotropium—asthma	0.00167	0.0026	CcSEcCtD
Naphazoline—Discomfort—Fluticasone Propionate—asthma	0.00167	0.00259	CcSEcCtD
Naphazoline—Headache—Ketotifen—asthma	0.00167	0.00259	CcSEcCtD
Naphazoline—Dizziness—Orciprenaline—asthma	0.00167	0.00259	CcSEcCtD
Naphazoline—Discomfort—Salmeterol—asthma	0.00166	0.00259	CcSEcCtD
Naphazoline—Sweating—Salbutamol—asthma	0.00166	0.00258	CcSEcCtD
Naphazoline—ADRA2C—trachea—asthma	0.00164	0.0422	CbGeAlD
Naphazoline—Dizziness—Nedocromil—asthma	0.00163	0.00253	CcSEcCtD
Naphazoline—Somnolence—Cromoglicic acid—asthma	0.00163	0.00253	CcSEcCtD
Naphazoline—Dizziness—Pirbuterol—asthma	0.00162	0.00252	CcSEcCtD
Naphazoline—Hyperhidrosis—Ipratropium bromide—asthma	0.00162	0.00251	CcSEcCtD
Naphazoline—Headache—Zileuton—asthma	0.00161	0.00251	CcSEcCtD
Naphazoline—Headache—Indacaterol—asthma	0.00159	0.00247	CcSEcCtD
Naphazoline—Asthenia—Zafirlukast—asthma	0.00159	0.00247	CcSEcCtD
Naphazoline—Nausea—Ketotifen—asthma	0.00158	0.00246	CcSEcCtD
Naphazoline—Headache—Orciprenaline—asthma	0.00158	0.00245	CcSEcCtD
Naphazoline—Dizziness—Fluticasone furoate—asthma	0.00156	0.00242	CcSEcCtD
Naphazoline—Vision blurred—Flunisolide—asthma	0.00155	0.00241	CcSEcCtD
Naphazoline—Headache—Nedocromil—asthma	0.00154	0.0024	CcSEcCtD
Naphazoline—Headache—Pirbuterol—asthma	0.00153	0.00238	CcSEcCtD
Naphazoline—Hypertension—Loratadine—asthma	0.00153	0.00238	CcSEcCtD
Naphazoline—Hypertension—Tiotropium—asthma	0.00153	0.00238	CcSEcCtD
Naphazoline—Nausea—Zileuton—asthma	0.00153	0.00238	CcSEcCtD
Naphazoline—Nausea—Indacaterol—asthma	0.00151	0.00234	CcSEcCtD
Naphazoline—Nausea—Orciprenaline—asthma	0.0015	0.00233	CcSEcCtD
Naphazoline—Discomfort—Loratadine—asthma	0.00149	0.00232	CcSEcCtD
Naphazoline—Somnolence—Ipratropium bromide—asthma	0.00149	0.00231	CcSEcCtD
Naphazoline—Headache—Fluticasone furoate—asthma	0.00148	0.00229	CcSEcCtD
Naphazoline—Nausea—Nedocromil—asthma	0.00146	0.00228	CcSEcCtD
Naphazoline—Dizziness—Zafirlukast—asthma	0.00146	0.00227	CcSEcCtD
Naphazoline—ADRA2A—bronchus—asthma	0.00146	0.0375	CbGeAlD
Naphazoline—Nausea—Pirbuterol—asthma	0.00145	0.00226	CcSEcCtD
Naphazoline—Asthenia—Ciclesonide—asthma	0.00145	0.00225	CcSEcCtD
Naphazoline—Hypertension—Flunisolide—asthma	0.00142	0.0022	CcSEcCtD
Naphazoline—ADRA1A—adrenal gland—asthma	0.00141	0.0363	CbGeAlD
Naphazoline—Eye disorder—Budesonide—asthma	0.0014	0.00218	CcSEcCtD
Naphazoline—Tension—Formoterol—asthma	0.0014	0.00218	CcSEcCtD
Naphazoline—Tension—Arformoterol—asthma	0.0014	0.00218	CcSEcCtD
Naphazoline—Nausea—Fluticasone furoate—asthma	0.0014	0.00217	CcSEcCtD
Naphazoline—Dizziness—Theophylline—asthma	0.00139	0.00216	CcSEcCtD
Naphazoline—Dizziness—Beclomethasone—asthma	0.00139	0.00216	CcSEcCtD
Naphazoline—Nervousness—Formoterol—asthma	0.00139	0.00216	CcSEcCtD
Naphazoline—Nervousness—Arformoterol—asthma	0.00139	0.00216	CcSEcCtD
Naphazoline—Headache—Zafirlukast—asthma	0.00139	0.00215	CcSEcCtD
Naphazoline—Discomfort—Flunisolide—asthma	0.00138	0.00215	CcSEcCtD
Naphazoline—ADRA2C—adrenal gland—asthma	0.00134	0.0346	CbGeAlD
Naphazoline—Dizziness—Ciclesonide—asthma	0.00133	0.00207	CcSEcCtD
Naphazoline—Tension—Salbutamol—asthma	0.00133	0.00206	CcSEcCtD
Naphazoline—Headache—Theophylline—asthma	0.00132	0.00205	CcSEcCtD
Naphazoline—Headache—Beclomethasone—asthma	0.00132	0.00205	CcSEcCtD
Naphazoline—Nausea—Zafirlukast—asthma	0.00131	0.00204	CcSEcCtD
Naphazoline—Asthenia—Cromoglicic acid—asthma	0.00131	0.00204	CcSEcCtD
Naphazoline—Nervousness—Salbutamol—asthma	0.00131	0.00204	CcSEcCtD
Naphazoline—ADRA2A—trachea—asthma	0.00131	0.0337	CbGeAlD
Naphazoline—Hyperhidrosis—Flunisolide—asthma	0.0013	0.00201	CcSEcCtD
Naphazoline—Somnolence—Loratadine—asthma	0.00129	0.002	CcSEcCtD
Naphazoline—Tension—Budesonide—asthma	0.00128	0.002	CcSEcCtD
Naphazoline—Nervousness—Budesonide—asthma	0.00127	0.00197	CcSEcCtD
Naphazoline—Headache—Ciclesonide—asthma	0.00126	0.00196	CcSEcCtD
Naphazoline—Nausea—Theophylline—asthma	0.00125	0.00194	CcSEcCtD
Naphazoline—Nausea—Beclomethasone—asthma	0.00125	0.00194	CcSEcCtD
Naphazoline—Hypertension—Formoterol—asthma	0.00123	0.00192	CcSEcCtD
Naphazoline—Hypertension—Arformoterol—asthma	0.00123	0.00192	CcSEcCtD
Naphazoline—Vision blurred—Budesonide—asthma	0.00123	0.00192	CcSEcCtD
Naphazoline—Dizziness—Cromoglicic acid—asthma	0.00121	0.00188	CcSEcCtD
Naphazoline—Discomfort—Formoterol—asthma	0.0012	0.00187	CcSEcCtD
Naphazoline—Discomfort—Arformoterol—asthma	0.0012	0.00187	CcSEcCtD
Naphazoline—Asthenia—Ipratropium bromide—asthma	0.0012	0.00187	CcSEcCtD
Naphazoline—Nausea—Ciclesonide—asthma	0.0012	0.00186	CcSEcCtD
Naphazoline—Eye pain—Dexamethasone—asthma	0.00119	0.00185	CcSEcCtD
Naphazoline—Eye pain—Betamethasone—asthma	0.00119	0.00185	CcSEcCtD
Naphazoline—ADRA2C—lung—asthma	0.00118	0.0303	CbGeAlD
Naphazoline—Hypertension—Salbutamol—asthma	0.00117	0.00181	CcSEcCtD
Naphazoline—Asthenia—Salmeterol—asthma	0.00116	0.0018	CcSEcCtD
Naphazoline—Headache—Cromoglicic acid—asthma	0.00115	0.00178	CcSEcCtD
Naphazoline—Discomfort—Salbutamol—asthma	0.00114	0.00177	CcSEcCtD
Naphazoline—Hypertension—Budesonide—asthma	0.00113	0.00176	CcSEcCtD
Naphazoline—Dizziness—Ipratropium bromide—asthma	0.00111	0.00172	CcSEcCtD
Naphazoline—Discomfort—Budesonide—asthma	0.0011	0.00171	CcSEcCtD
Naphazoline—Nausea—Cromoglicic acid—asthma	0.00109	0.00169	CcSEcCtD
Naphazoline—ADRA2A—adrenal gland—asthma	0.00107	0.0276	CbGeAlD
Naphazoline—Dizziness—Fluticasone Propionate—asthma	0.00107	0.00166	CcSEcCtD
Naphazoline—Dizziness—Salmeterol—asthma	0.00107	0.00166	CcSEcCtD
Naphazoline—Hyperhidrosis—Salbutamol—asthma	0.00107	0.00166	CcSEcCtD
Naphazoline—Headache—Ipratropium bromide—asthma	0.00105	0.00163	CcSEcCtD
Naphazoline—Asthenia—Loratadine—asthma	0.00104	0.00162	CcSEcCtD
Naphazoline—Somnolence—Formoterol—asthma	0.00104	0.00161	CcSEcCtD
Naphazoline—Somnolence—Arformoterol—asthma	0.00104	0.00161	CcSEcCtD
Naphazoline—Hyperhidrosis—Budesonide—asthma	0.00103	0.0016	CcSEcCtD
Naphazoline—Somnolence—Montelukast—asthma	0.00102	0.00158	CcSEcCtD
Naphazoline—Dizziness—Aminophylline—asthma	0.00101	0.00158	CcSEcCtD
Naphazoline—Headache—Fluticasone Propionate—asthma	0.00101	0.00158	CcSEcCtD
Naphazoline—Headache—Salmeterol—asthma	0.00101	0.00157	CcSEcCtD
Naphazoline—Nausea—Ipratropium bromide—asthma	0.000993	0.00154	CcSEcCtD
Naphazoline—Somnolence—Salbutamol—asthma	0.00098	0.00152	CcSEcCtD
Naphazoline—Asthenia—Flunisolide—asthma	0.000962	0.0015	CcSEcCtD
Naphazoline—Nausea—Fluticasone Propionate—asthma	0.000962	0.00149	CcSEcCtD
Naphazoline—Headache—Aminophylline—asthma	0.000961	0.00149	CcSEcCtD
Naphazoline—Nausea—Salmeterol—asthma	0.000959	0.00149	CcSEcCtD
Naphazoline—Dizziness—Loratadine—asthma	0.000958	0.00149	CcSEcCtD
Naphazoline—Dizziness—Tiotropium—asthma	0.000956	0.00149	CcSEcCtD
Naphazoline—Somnolence—Budesonide—asthma	0.000949	0.00148	CcSEcCtD
Naphazoline—ADRA2A—lung—asthma	0.000939	0.0242	CbGeAlD
Naphazoline—Nausea—Aminophylline—asthma	0.000911	0.00142	CcSEcCtD
Naphazoline—Headache—Loratadine—asthma	0.000908	0.00141	CcSEcCtD
Naphazoline—Headache—Tiotropium—asthma	0.000906	0.00141	CcSEcCtD
Naphazoline—Asthenia—Mometasone—asthma	0.000892	0.00139	CcSEcCtD
Naphazoline—Dizziness—Flunisolide—asthma	0.000886	0.00138	CcSEcCtD
Naphazoline—Sweating—Methylprednisolone—asthma	0.000872	0.00136	CcSEcCtD
Naphazoline—Nausea—Loratadine—asthma	0.000861	0.00134	CcSEcCtD
Naphazoline—Nausea—Tiotropium—asthma	0.000859	0.00134	CcSEcCtD
Naphazoline—Headache—Flunisolide—asthma	0.00084	0.00131	CcSEcCtD
Naphazoline—Asthenia—Arformoterol—asthma	0.000837	0.0013	CcSEcCtD
Naphazoline—Asthenia—Formoterol—asthma	0.000837	0.0013	CcSEcCtD
Naphazoline—Hyperglycaemia—Betamethasone—asthma	0.000837	0.0013	CcSEcCtD
Naphazoline—Hyperglycaemia—Dexamethasone—asthma	0.000837	0.0013	CcSEcCtD
Naphazoline—Asthenia—Montelukast—asthma	0.00082	0.00128	CcSEcCtD
Naphazoline—Eye disorder—Hydrocortisone—asthma	0.000812	0.00126	CcSEcCtD
Naphazoline—Nausea—Flunisolide—asthma	0.000796	0.00124	CcSEcCtD
Naphazoline—Asthenia—Salbutamol—asthma	0.000791	0.00123	CcSEcCtD
Naphazoline—Headache—Mometasone—asthma	0.000779	0.00121	CcSEcCtD
Naphazoline—Erythema—Prednisolone—asthma	0.000775	0.0012	CcSEcCtD
Naphazoline—Dizziness—Arformoterol—asthma	0.000772	0.0012	CcSEcCtD
Naphazoline—Dizziness—Formoterol—asthma	0.000772	0.0012	CcSEcCtD
Naphazoline—Asthenia—Budesonide—asthma	0.000766	0.00119	CcSEcCtD
Naphazoline—Eye disorder—Methylprednisolone—asthma	0.000763	0.00119	CcSEcCtD
Naphazoline—Erythema—Hydrocortisone—asthma	0.000756	0.00118	CcSEcCtD
Naphazoline—Dizziness—Montelukast—asthma	0.000756	0.00118	CcSEcCtD
Naphazoline—Nausea—Mometasone—asthma	0.000739	0.00115	CcSEcCtD
Naphazoline—Headache—Formoterol—asthma	0.000731	0.00114	CcSEcCtD
Naphazoline—Headache—Arformoterol—asthma	0.000731	0.00114	CcSEcCtD
Naphazoline—Vision blurred—Prednisolone—asthma	0.00073	0.00113	CcSEcCtD
Naphazoline—Dizziness—Salbutamol—asthma	0.000729	0.00113	CcSEcCtD
Naphazoline—Hyperglycaemia—Prednisone—asthma	0.000729	0.00113	CcSEcCtD
Naphazoline—Headache—Montelukast—asthma	0.000716	0.00111	CcSEcCtD
Naphazoline—Erythema—Triamcinolone—asthma	0.000712	0.00111	CcSEcCtD
Naphazoline—Erythema—Methylprednisolone—asthma	0.000711	0.0011	CcSEcCtD
Naphazoline—Dizziness—Budesonide—asthma	0.000706	0.0011	CcSEcCtD
Naphazoline—Eye disorder—Dexamethasone—asthma	0.000694	0.00108	CcSEcCtD
Naphazoline—Eye disorder—Betamethasone—asthma	0.000694	0.00108	CcSEcCtD
Naphazoline—Nausea—Arformoterol—asthma	0.000693	0.00108	CcSEcCtD
Naphazoline—Nausea—Formoterol—asthma	0.000693	0.00108	CcSEcCtD
Naphazoline—Headache—Salbutamol—asthma	0.00069	0.00107	CcSEcCtD
Naphazoline—Nausea—Montelukast—asthma	0.000679	0.00106	CcSEcCtD
Naphazoline—Headache—Budesonide—asthma	0.000669	0.00104	CcSEcCtD
Naphazoline—Hypertension—Prednisolone—asthma	0.000669	0.00104	CcSEcCtD
Naphazoline—Nausea—Salbutamol—asthma	0.000655	0.00102	CcSEcCtD
Naphazoline—Hypertension—Hydrocortisone—asthma	0.000653	0.00102	CcSEcCtD
Naphazoline—Discomfort—Prednisolone—asthma	0.000652	0.00101	CcSEcCtD
Naphazoline—Erythema—Betamethasone—asthma	0.000646	0.001	CcSEcCtD
Naphazoline—Erythema—Dexamethasone—asthma	0.000646	0.001	CcSEcCtD
Naphazoline—Discomfort—Hydrocortisone—asthma	0.000636	0.000989	CcSEcCtD
Naphazoline—Nausea—Budesonide—asthma	0.000634	0.000986	CcSEcCtD
Naphazoline—Hypertension—Triamcinolone—asthma	0.000615	0.000956	CcSEcCtD
Naphazoline—Hypertension—Methylprednisolone—asthma	0.000614	0.000954	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisolone—asthma	0.000611	0.00095	CcSEcCtD
Naphazoline—Eye disorder—Prednisone—asthma	0.000604	0.000939	CcSEcCtD
Naphazoline—Discomfort—Triamcinolone—asthma	0.000599	0.000931	CcSEcCtD
Naphazoline—Discomfort—Methylprednisolone—asthma	0.000598	0.000929	CcSEcCtD
Naphazoline—Hyperhidrosis—Hydrocortisone—asthma	0.000597	0.000928	CcSEcCtD
Naphazoline—Erythema—Prednisone—asthma	0.000563	0.000875	CcSEcCtD
Naphazoline—Hyperhidrosis—Triamcinolone—asthma	0.000562	0.000874	CcSEcCtD
Naphazoline—Hyperhidrosis—Methylprednisolone—asthma	0.000561	0.000872	CcSEcCtD
Naphazoline—Hypertension—Dexamethasone—asthma	0.000558	0.000867	CcSEcCtD
Naphazoline—Hypertension—Betamethasone—asthma	0.000558	0.000867	CcSEcCtD
Naphazoline—Discomfort—Betamethasone—asthma	0.000544	0.000845	CcSEcCtD
Naphazoline—Discomfort—Dexamethasone—asthma	0.000544	0.000845	CcSEcCtD
Naphazoline—Vision blurred—Prednisone—asthma	0.00053	0.000825	CcSEcCtD
Naphazoline—Hyperhidrosis—Dexamethasone—asthma	0.00051	0.000793	CcSEcCtD
Naphazoline—Hyperhidrosis—Betamethasone—asthma	0.00051	0.000793	CcSEcCtD
Naphazoline—Hypertension—Prednisone—asthma	0.000486	0.000755	CcSEcCtD
Naphazoline—Discomfort—Prednisone—asthma	0.000473	0.000736	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisone—asthma	0.000444	0.00069	CcSEcCtD
Naphazoline—Asthenia—Hydrocortisone—asthma	0.000443	0.000689	CcSEcCtD
Naphazoline—Dizziness—Prednisolone—asthma	0.000418	0.00065	CcSEcCtD
Naphazoline—Asthenia—Triamcinolone—asthma	0.000417	0.000648	CcSEcCtD
Naphazoline—Asthenia—Methylprednisolone—asthma	0.000416	0.000647	CcSEcCtD
Naphazoline—Dizziness—Hydrocortisone—asthma	0.000408	0.000635	CcSEcCtD
Naphazoline—Headache—Prednisolone—asthma	0.000396	0.000616	CcSEcCtD
Naphazoline—Headache—Hydrocortisone—asthma	0.000387	0.000601	CcSEcCtD
Naphazoline—Dizziness—Triamcinolone—asthma	0.000384	0.000598	CcSEcCtD
Naphazoline—Dizziness—Methylprednisolone—asthma	0.000384	0.000596	CcSEcCtD
Naphazoline—Asthenia—Betamethasone—asthma	0.000378	0.000588	CcSEcCtD
Naphazoline—Asthenia—Dexamethasone—asthma	0.000378	0.000588	CcSEcCtD
Naphazoline—Nausea—Prednisolone—asthma	0.000375	0.000584	CcSEcCtD
Naphazoline—Nausea—Hydrocortisone—asthma	0.000367	0.00057	CcSEcCtD
Naphazoline—Headache—Triamcinolone—asthma	0.000364	0.000566	CcSEcCtD
Naphazoline—Headache—Methylprednisolone—asthma	0.000363	0.000565	CcSEcCtD
Naphazoline—Dizziness—Dexamethasone—asthma	0.000349	0.000542	CcSEcCtD
Naphazoline—Dizziness—Betamethasone—asthma	0.000349	0.000542	CcSEcCtD
Naphazoline—Nausea—Triamcinolone—asthma	0.000345	0.000537	CcSEcCtD
Naphazoline—Nausea—Methylprednisolone—asthma	0.000345	0.000536	CcSEcCtD
Naphazoline—Headache—Dexamethasone—asthma	0.00033	0.000514	CcSEcCtD
Naphazoline—Headache—Betamethasone—asthma	0.00033	0.000514	CcSEcCtD
Naphazoline—Asthenia—Prednisone—asthma	0.00033	0.000512	CcSEcCtD
Naphazoline—Nausea—Dexamethasone—asthma	0.000313	0.000487	CcSEcCtD
Naphazoline—Nausea—Betamethasone—asthma	0.000313	0.000487	CcSEcCtD
Naphazoline—Dizziness—Prednisone—asthma	0.000304	0.000472	CcSEcCtD
Naphazoline—Headache—Prednisone—asthma	0.000288	0.000447	CcSEcCtD
Naphazoline—Nausea—Prednisone—asthma	0.000273	0.000424	CcSEcCtD
Naphazoline—ADRA2A—GPCR downstream signaling—IL2RA—asthma	6.21e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR3—asthma	6.17e-05	0.000194	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCR5—asthma	6.16e-05	0.000194	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—C3—asthma	6.16e-05	0.000194	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—BDKRB2—asthma	6.07e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL2RA—asthma	6.07e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—POMC—asthma	6.06e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—VEGFA—asthma	6.03e-05	0.00019	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—C3—asthma	6.02e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NPY—asthma	6.01e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GSTP1—asthma	5.99e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EDNRB—asthma	5.98e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB1—asthma	5.92e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TAC1—asthma	5.92e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NPS—asthma	5.92e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KNG1—asthma	5.91e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—HMOX1—asthma	5.9e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—POMC—asthma	5.89e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ITPR1—asthma	5.89e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGTR1—asthma	5.88e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADCY2—asthma	5.87e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL3—asthma	5.85e-05	0.000184	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NQO1—asthma	5.83e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CAT—asthma	5.83e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PPP2CA—asthma	5.82e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCR3—asthma	5.8e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGTR2—asthma	5.8e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCL2—asthma	5.77e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—IL2—asthma	5.76e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6R—asthma	5.75e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL10—asthma	5.74e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCR5—asthma	5.72e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—RHOA—asthma	5.72e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ADCY2—asthma	5.71e-05	0.000179	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL2RA—asthma	5.64e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NTRK1—asthma	5.63e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CYBA—asthma	5.62e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—C3—asthma	5.59e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRB2—asthma	5.57e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EDNRB—asthma	5.55e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB1—asthma	5.53e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KNG1—asthma	5.52e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—POMC—asthma	5.5e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PLA2G4A—asthma	5.5e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GSTM1—asthma	5.5e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PARP1—asthma	5.5e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL5—asthma	5.5e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NPS—asthma	5.5e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TAC1—asthma	5.5e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGTR1—asthma	5.49e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCR3—asthma	5.39e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCL2—asthma	5.39e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6R—asthma	5.37e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL10—asthma	5.36e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—RHOA—asthma	5.34e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—BDKRB2—asthma	5.31e-05	0.000167	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—POMC—asthma	5.3e-05	0.000167	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ITPR1—asthma	5.27e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NTRK1—asthma	5.26e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CYBA—asthma	5.22e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRB2—asthma	5.21e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—RHOA—asthma	5.19e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADCY2—asthma	5.13e-05	0.000162	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL3—asthma	5.12e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL5—asthma	5.11e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PARP1—asthma	5.11e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPP2CA—asthma	5.07e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CD86—asthma	5.02e-05	0.000158	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCL8—asthma	5.02e-05	0.000158	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EDN1—asthma	4.98e-05	0.000157	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL5—asthma	4.94e-05	0.000156	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BDKRB2—asthma	4.93e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ITPR1—asthma	4.93e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PLA2G4A—asthma	4.92e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—POMC—asthma	4.92e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—asthma	4.89e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CSF2—asthma	4.87e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTP1—asthma	4.86e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—RHOA—asthma	4.85e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KNG1—asthma	4.83e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—POMC—asthma	4.81e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGTR1—asthma	4.8e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—IL2—asthma	4.8e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HMOX1—asthma	4.8e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ITPR1—asthma	4.78e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADCY2—asthma	4.77e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL3—asthma	4.75e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SMAD3—asthma	4.74e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CAT—asthma	4.73e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCL2—asthma	4.71e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6R—asthma	4.69e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CD86—asthma	4.69e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL10—asthma	4.69e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCL8—asthma	4.69e-05	0.000147	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—RHOA—asthma	4.67e-05	0.000147	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EDN1—asthma	4.65e-05	0.000146	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL5—asthma	4.62e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NTRK1—asthma	4.6e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PLA2G4A—asthma	4.6e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCL8—asthma	4.56e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB2—asthma	4.55e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CSF2—asthma	4.55e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PPP2CA—asthma	4.54e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—asthma	4.49e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KNG1—asthma	4.49e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—IL2—asthma	4.48e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—POMC—asthma	4.47e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PLA2G4A—asthma	4.47e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTM1—asthma	4.47e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGTR1—asthma	4.46e-05	0.00014	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCR5—asthma	4.45e-05	0.00014	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SMAD3—asthma	4.43e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL2RA—asthma	4.39e-05	0.000138	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL2—asthma	4.37e-05	0.000138	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6R—asthma	4.36e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL10—asthma	4.36e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL2—asthma	4.36e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—C3—asthma	4.35e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—RHOA—asthma	4.34e-05	0.000136	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ITPR1—asthma	4.31e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NTRK1—asthma	4.27e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCL8—asthma	4.26e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—RHOA—asthma	4.24e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PPP2CA—asthma	4.24e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PDGFB—asthma	4.24e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB2—asthma	4.23e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCR5—asthma	4.16e-05	0.000131	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPP2CA—asthma	4.12e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CD86—asthma	4.1e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL2RA—asthma	4.1e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL8—asthma	4.1e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL2—asthma	4.07e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EDN1—asthma	4.07e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—C3—asthma	4.07e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—asthma	4.05e-05	0.000127	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL5—asthma	4.04e-05	0.000127	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PLA2G4A—asthma	4.02e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ITPR1—asthma	4e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CSF2—asthma	3.98e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PDGFB—asthma	3.96e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—RHOA—asthma	3.94e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—IL2—asthma	3.92e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—asthma	3.89e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SMAD3—asthma	3.87e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FN1—asthma	3.82e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CD86—asthma	3.81e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL8—asthma	3.81e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—asthma	3.78e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EDN1—asthma	3.78e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL5—asthma	3.75e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLA2G4A—asthma	3.74e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL8—asthma	3.72e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PPP2CA—asthma	3.7e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CSF2—asthma	3.69e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—IL2—asthma	3.64e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR5—asthma	3.64e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SMAD3—asthma	3.6e-05	0.000113	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL2RA—asthma	3.58e-05	0.000113	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FN1—asthma	3.57e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL2—asthma	3.56e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—C3—asthma	3.55e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—asthma	3.54e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—asthma	3.48e-05	0.000109	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PDGFB—asthma	3.46e-05	0.000109	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL8—asthma	3.46e-05	0.000109	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PPP2CA—asthma	3.44e-05	0.000108	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL2—asthma	3.41e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6R—asthma	3.4e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NOS3—asthma	3.39e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR5—asthma	3.38e-05	0.000106	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—asthma	3.33e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL2RA—asthma	3.33e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—asthma	3.31e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL2—asthma	3.3e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—C3—asthma	3.3e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—asthma	3.25e-05	0.000102	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PDGFB—asthma	3.21e-05	0.000101	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL2—asthma	3.18e-05	0.0001	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SERPINE1—asthma	3.18e-05	0.0001	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6R—asthma	3.17e-05	9.98e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—asthma	3.16e-05	9.93e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FN1—asthma	3.12e-05	9.82e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—asthma	3.11e-05	9.79e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—asthma	3.1e-05	9.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—asthma	3.07e-05	9.67e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RHOA—asthma	3.07e-05	9.65e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOS3—asthma	3.04e-05	9.55e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SERPINE1—asthma	2.97e-05	9.34e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FN1—asthma	2.9e-05	9.12e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—asthma	2.88e-05	9.06e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RHOA—asthma	2.86e-05	9.01e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—asthma	2.84e-05	8.94e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOS3—asthma	2.84e-05	8.92e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL2—asthma	2.78e-05	8.75e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6R—asthma	2.77e-05	8.72e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NOS3—asthma	2.75e-05	8.66e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—asthma	2.72e-05	8.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTEN—asthma	2.7e-05	8.51e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL8—asthma	2.69e-05	8.47e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—asthma	2.64e-05	8.31e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SERPINE1—asthma	2.6e-05	8.17e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL2—asthma	2.58e-05	8.13e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6R—asthma	2.58e-05	8.1e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL2—asthma	2.57e-05	8.09e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—asthma	2.56e-05	8.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—asthma	2.53e-05	7.95e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—asthma	2.52e-05	7.92e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL8—asthma	2.52e-05	7.91e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RHOA—asthma	2.5e-05	7.88e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOS3—asthma	2.48e-05	7.8e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—asthma	2.44e-05	7.66e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PTEN—asthma	2.42e-05	7.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SERPINE1—asthma	2.41e-05	7.59e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL2—asthma	2.4e-05	7.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—asthma	2.39e-05	7.52e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RHOA—asthma	2.33e-05	7.32e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOS3—asthma	2.3e-05	7.24e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—asthma	2.27e-05	7.16e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTEN—asthma	2.26e-05	7.11e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL8—asthma	2.2e-05	6.92e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTEN—asthma	2.2e-05	6.91e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—asthma	2.19e-05	6.88e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STAT3—asthma	2.17e-05	6.81e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL2—asthma	2.1e-05	6.61e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—asthma	2.09e-05	6.58e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL8—asthma	2.04e-05	6.43e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—asthma	2.04e-05	6.43e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STAT3—asthma	2.02e-05	6.36e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—asthma	2.01e-05	6.31e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—asthma	1.99e-05	6.26e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTEN—asthma	1.98e-05	6.22e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—asthma	1.97e-05	6.19e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL2—asthma	1.95e-05	6.14e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—asthma	1.94e-05	6.11e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—asthma	1.87e-05	5.9e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—asthma	1.85e-05	5.81e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—asthma	1.84e-05	5.78e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTEN—asthma	1.84e-05	5.78e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—asthma	1.79e-05	5.62e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STAT3—asthma	1.77e-05	5.56e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—asthma	1.66e-05	5.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STAT3—asthma	1.64e-05	5.17e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—asthma	1.64e-05	5.16e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—asthma	1.61e-05	5.06e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—asthma	1.52e-05	4.79e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—asthma	1.51e-05	4.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—asthma	1.49e-05	4.7e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—asthma	1.41e-05	4.44e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—asthma	1.24e-05	3.89e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—asthma	1.15e-05	3.61e-05	CbGpPWpGaD
